China has announced that a vaccine for Coronavirus may be available for use by the general public in November, 2020.
Producers of vaccine worldwide are racing against time to manufacture an effective vaccine against the virus which has killed above 925,000 people.
Already, China has four COVID-19 vaccines in the last stage of clinical trials and have administered three of those drugs to essential workers under an emergency use programme launched in July.
While announcing this, Guizhen Wu, a highly ranked official of the Chinese Centre for Disease Control and Prevention, said the coronavirus vaccines being manufactured in China may be ready for use by the general public as the phase three clinical trials were going according to plan.
During an interview with State TV, Wu also revealed she contracted Coronavirus but she has not encountered any abnormal symptom in recent months after taking the experimental vaccine in April.
An arm of state pharmaceutical giant, China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech are putting the three vaccines in place under the state’s emergency use programme.
At present, there are nine vaccine candidates in late-stage human trials, though some have experienced recent obstacles as AstraZeneca and Oxford University paused clinical trials recently after a volunteer had an unexplained illness.
